# Loqtorzi

Type: Product

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/loqtorzi
Canonical HTML page: https://getbiobrief.com/entity/loqtorzi

## Recent coverage (1 stories)

### Coherus BioSciences Q4 2025 Preview: Oncology Pivot and Udenyca Onbody Growth
2026-03-08 22:54:39 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Coherus BioSciences is set to report Q4 2025 earnings as it completes its strategic transition into a pure-play oncology firm. Investors are focused on the commercial ramp of Loqtorzi and the market share recovery of the Udenyca franchise following the launch of its Onbody injector.
Full story: https://getbiobrief.com/story/coherus-biosciences-q4-2025-earnings-preview-oncology-strategy

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.